Alfredo Pascual

Alfredo Pascual, CFA is Head of Strategy & Corporate Development at Cannamedical, one of Europe’s leading independent medical cannabis companies. He brings a decade of experience in investment analysis, capital allocation, and market and regulatory intelligence within the cannabis industry.

Before joining Cannamedical, Alfredo spent nearly five years at Seed Innovations Ltd (LON:SEED), an AIM-quoted fund focused on the cannabis sector, serving as Executive Director and previously as VP of Investment Analysis. He also served on the Supervisory Board of Avextra, a German pharmaceutical cannabis manufacturer. More recently, he executed independent strategic and financial mandates for European cannabis operators, including leading M&A due diligence and market entry strategy for Little Green Pharma (ASX:LGP), and briefly directing market sizing and product at Prohibition Partners. Earlier, he spent three years as International Analyst at MJBizDaily.

Alfredo is a CFA Charterholder with an MA in Governance and Public Policy from Universität Passau and a BBA from Universidad Católica del Uruguay, complemented by certifications in pharmaceutical drug regulation.